Intraocular Pressure and Medication Changes Associated with Xen Gel Stent: A Systematic Review of the Literature

The Xen gel stent (Allergan Inc, an AbbVie company; Dublin, Ireland) was conceived as an option for patients requiring modest IOP reduction but for whom trabeculectomy was not yet indicated. As with any glaucoma surgery, establishing criteria for patient selection and identifying factors that contri...

Descripción completa

Detalles Bibliográficos
Autores principales: Panarelli, Joseph F, Vera, Vanessa, Sheybani, Arsham, Radcliffe, Nathan, Fiscella, Richard, Francis, Brian A, Smith, Oluwatosin U, Noecker, Robert J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845068/
https://www.ncbi.nlm.nih.gov/pubmed/36660309
http://dx.doi.org/10.2147/OPTH.S390955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845068/
https://www.ncbi.nlm.nih.gov/pubmed/36660309
http://dx.doi.org/10.2147/OPTH.S390955

Ejemplares similares